FDA product code PWD: Flow Cytometric Test System For Hematopoietic Neoplasms

PWD is the FDA product code for flow cytometric test system for hematopoietic neoplasms. It is a Class II device, regulated under 21 CFR 864.7010 and reviewed by the Hematology panel. FDA has cleared 1 510(k) submission under PWD. The average 510(k) review took 90 days (median 90). 1 De Novo request was granted under it.

Definition

Reagents intended for in vitro diagnostic use as a panel for qualitative identification of cell populations by multiparameter immunophenotyping on a flow cytometer. These reagents are used as an aid in the differential diagnosis of hematologically abnormal patients having, or suspected of having the following hematopoietic neoplasms: chronic leukemia, acute leukemia, non-Hodgkin's lymphoma, myeloma, myelodysplastic syndrome (MDS), and/or myeloproliferative neoplasms (MPN)

Classification

FieldValue
Device nameFlow Cytometric Test System For Hematopoietic Neoplasms
Device classClass II
Regulation21 CFR 864.7010
Review panelHE — Hematology
Medical specialtyHematology
Premarket route510(k)
Third-party 510(k) review eligibleYes

510(k) clearances per year for PWD

YearClearancesAvg. review days
2019190

Compare with all 510(k) review times · Search every PWD clearance

Top PWD applicants

ApplicantClearancesLatest
Beckman Coulter12019-03-21

Most recent PWD clearances

510(k)ApplicantDeviceDecision dateReview days
K183592Beckman CoulterClearLLab 10C Panels (B, T, M1, M2), Navios Flow Cytometer, Navios EX Flow Cytometer2019-03-2190

Recalls for PWD devices

openFDA lists no recalls for product code PWD.

Frequently asked questions

What is FDA product code PWD?

PWD is the FDA product code for flow cytometric test system for hematopoietic neoplasms. It is a Class II device, regulated under 21 CFR 864.7010 and reviewed by the Hematology panel.

What device class is PWD?

Class II, regulation 21 CFR 864.7010. Typical premarket route: 510(k).

How long does a 510(k) take for product code PWD?

Across 1 cleared submissions the average was 90 days from receipt to decision (median 90).

Which companies have the most PWD clearances?

Beckman Coulter (1).

Next steps

Source: openFDA device classification, 510(k), PMA, De Novo and recall data (public domain). Review days run from FDA receipt to decision. Not regulatory advice.

All Hematology product codes · FDA product code lookup · 510(k) database search · 510(k) review times